Girindus Not Affected by Solvay's Decision to Sell Pharmaceuticals Sector

Published: Sep 29, 2009

BERGISCH GLADBACH, Germany & CINCINNATI, Ohio--(BUSINESS WIRE)--Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.

Back to news